Ronald E. Blaylock, a director at Pfizer Inc. (NYSE:PFE), purchased 19,457 shares of the company's common stock. The ...

Results from a new study published in Clinical and Translational Immunology found that dual-target antibody therapy can enhance cancer-fighting T cells more effectively than current single-target ...

The Pentagon says the military services must again ask troops who were forced out or who voluntarily left the military due to ...

Major bleeding was low overall, but the findings align with other large datasets showing greater risk with rivaroxaban.

Combining talazoparib with enzalutamide significantly improves overall survival in patients with metastatic ...

Bristol Myers Squibb Co. devoted half a page of its annual report to its diversity, equity and inclusion efforts, going so ...

Researchers, led by the University of Melbourne's Professor Laura Mackay, a Laboratory Head and Immunology Theme Leader at the Peter Doherty Institute of Infection and Immunity (Doherty Institute), in ...